19/04/28
Preclinical study of MSCs modified with HGF in the treatment of lung injury( chronic obstructive pulmonary disease / pulmonary fibrosis / paraquat)
Gene modified enhanced MSCs, as a second-generation product, has the dual advantages of cell therapy and gene the
MORE